Aw. Hemming et al., A PHARMACOECONOMIC ANALYSIS OF NEORAL WITHOUT INTRAVENOUS CYCLOSPORINE IN LIVER-TRANSPLANTATION IN CANADA, Clinical transplantation, 12(5), 1998, pp. 425-429
Neoral, a microemulsion formulation of cyclosporin A (CsA), has improv
ed absorption compared to Sandimmune and has allowed induction of immu
nosuppression in liver transplantation (LT) without the use of intrave
nous (IV) CsA. The improved bioavailability with less inter- and intra
-patient dosing variability coupled with the lack of requirement for I
V CsA may provide a mechanism for cost savings when Neoral is used for
induction immunosuppression. This retrospective case-control study co
mpares the relative costs associated with Neoral induction without IV
CsA versus induction with IV CsA followed by oral CsA in adult liver t
ransplant recipients. Twenty consecutive patients receiving Neoral 12-
15 mg/kg per d were compared to a control group of 21 patients receivi
ng IV CsA followed by oral CsA for induction. Both groups received the
same rapidly tapered dose of methyl-prednisilone. Health care resourc
e utilization was assigned based on days in hospital and acute rejecti
on episodes (ARE). Hospital per diem rates at specified care levels we
re used to assign costs associated with hospital stay, while a previou
sly developed case-costing model was used to assign costs to episodes
of acute rejection. All patients were followed for a 3-month period po
st-transplant. Although there was a trend towards shorter hospital sta
y in the Neoral group the majority of cost savings were achieved by re
ducing costs associated with episodes of acute rejection. There were s
even and 19 episodes of ARE in the Neoral and IV CsA groups respective
ly (p < 0.05.) A separate cost effective assessment of the effect of r
educing rejection by decision tree analysis demonstrated a cost reduct
ion of $2162 per patient. The savings achieved with Neoral proved robu
st on sensitivity analysis. The change of practice to an induction imm
unosuppression regimen of Neoral without IV CsA has achieved a cost sa
vings in adult river transplantation at our center.